Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Starting at $ 115 / Month GLP-1 receptor agonist that is FDA-approved for chronic weight management Wegovy Adults with obesity (BMI 30) or overweight (BMI 27 with a weight-related condition such as hypertension, diabetes, or high cholesterol) Start todayMore Info Potential Weight Loss* Administration methods** Injections Dose frequency*** Weekly Potential side effects Possible side effects may include nausea, vomiting, constipation, diarrhea, indigestion or stomach discomfort, reduced appetite, headache, fatigue, or injection site reactionsespecially when starting or increasing the dose
How does Retatrutide differ from Semaglutide and Tirzepatide
And although by law they must contain the same active ingredient as the drug they mimic, these orally formulated medications may not work nearly as well as the injectable drugs
In teaming up with Williams, Ros goal is to destigmatize the use of GLP-1 treatments for weight loss.
US$ 27.49
US$ 27.79
US$ 22.99
US$ 26.64
US$ 27.08
US$ 26.02
US$ 24.92
US$ 25.42
